Skip to main content

Table 1 Selected population IPD and CAP disease burden estimates for PCV13 serotype CAP

From: A systematic review of the burden of vaccine preventable pneumococcal disease in UK adults

Study Population Year Incidence/100,000
Waight et al [21] England and Wales
IPD – all ages
2013/14 1.40
Waight et al [21] England and Wales
IPD- age >65 years
2013/14 3.72
Rodrigo et al [29] Nottingham (multicentre)
CAP- adults all ages
2012/13 8.60
Rodrigo et al [29] Nottingham (multicentre)
CAP- Age >65 years
2012/13 16.75
Van Hoek et al [39] England
Risk groupsa Adult
2008/9 37.10b
Van Hoek et al [39] England
Risk groupsa ≥65 years
2008/9 39.84b
  1. CAP refers to non-invasive and invasive pneumococcal community acquired pneumonia
  2. arisk groups include asplenia/splenic dysfunction/chronic respiratory disease/chronic heart disease/chronic kidney disease/chronic liver disease/diabetes/immunosuppression/cochlear implants/cerebrospinal fluid leaks [39]
  3. bdata extracted based on reported 83 % coverage of total IPD incidence by PCV13 during 2008/9